|
FBLG Fibrobiologics Inc 1958777 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-4,117,000.00 |
| Balance Sheet |
|
Current Assets
|
$5,850,000.00 |
|
Assets
|
$7,929,000.00 |
|
Current Liabilities
|
$2,213,000.00 |
|
Liabilities
|
$3,293,000.00 |
|
Equity
|
$4,636,000.00 |
|
Shares Out
|
6658193.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-7,655,000.00 |
| Market Analysis |
Market Cap
|
$8,589,068.97 |
|
Price
|
$1.29 |
|
BVPS
|
0.70 |
|
PB
|
1.84 |
|
EPS
|
-0.66 |
|
FCF
|
$-7,655,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:04 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FBLG documents filed with the SEC.
FBLG Filings
Clear
